1/12/2007
Mannatech Glyconutrients - Glyconutrients, Glyconutritionals
Glyconutritionals - Our body requires 8 different essential glyconutritionals but only 2 of those are found in any amount in our modern day diets. This is why we should take a complete glyconutrient supplement. Without it, our body will be unable to properly build glycoproteins, which can cause great detriment to our health. At this Glyconutrients Site, you will find all the up-to-date information on glyconutritionals. -President Bush: ?frivolous asbestos claims.?
Sometimes the ironic timing of events in our public life is so striking as to cause one to wonder whether the Great Scriptwriter in the Sky is trying to make a point. Thus, the word that the Senate voted for tort deform last week came just a few days after ...
Asbestos Indictment Rallies Montanans
They're getting ready for the Asbestos Health Fair in this old mining town. Posters promise "Door Prizes!!" and "Blood draw to participate in ongoing research!" Companies that sell home oxygen supplies will send reps. Doctors and researchers will be here. There will be consultants to help asbestosis victims apply for ...
asbestos reform and asbestos related litigation is on fire?
On the subject of blog business models, Michael Buffington explains how he launched Asbestos News, a niche content blog designed to generate money via Google AdWords based on content supplied by Google Alerts: The subject matter, while weighty and all that, is of little importance to ...
Companies Look to Plug the Asbestos Drain
Proponents of a bill to rein in asbestos lawsuits say this could be the year legislation is finally approved on Capitol Hill. Court cases have cost companies billions of dollars, while also helping to push dozens of firms into bankruptcy. But given the mounting debate over the proposed legislation, ...
Malignant Pleural Mesothelioma European Prognosis Score Validated
European Prognosis Score Validated in Malignant Pleural Mesothelioma: A recent article in the Journal of Clinical Oncology reports that the current model for determining the prognosis for malignant pleural mesothelioma (MPM) is a valid tool for determining high and low-risk patients for clinical trial participation. The current model for determining the ...

